| Sign In to gain access to subscriptions and/or personal tools. |
Preclinical Restenosis Models: Challenges and SuccessesMinneapolis Heart Institute, Minneapolis, Minnesota 55407, USA Correspondence: Address correspondence to: Robert S. Schwartz, Minneapolis Heart Institute, Minnesota Cardiovascular Research Institute, 928 E. 28th St., Minneapolis, MN 55407, USA; e-mail:rss{at}rsschwartz.com Coronary artery disease remains a major problem for Western societies. The advent of percutaneous interventions, including stents has brought clinical care to a new level of efficacy, yet problems remain. Restenosis following stenting in human coronary arteries appears at last to be yielding to therapeutic strategies, especially drug eluting stents. Because therapeutic percutaneous coronary intervention is widely dominated by the intracoronary stent, restenosis therapies must include the stented coronary artery. Animal models and in particular the porcine coronary model seem to represent the human coronary artery reaction to stenting. It mimics several clinical conditions including thrombosis and neointimal formation. A key question in the era of intravascular technologies is how well this and other models can predict clinical events. This paper discusses the models and their application.
Key Words: Neointima • restenosis • stent • vascular injury
Toxicologic Pathology, Vol. 34, No. 1,
11-18 (2006) This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
 |
|
Sign In to gain access to subscriptions and/or personal tools.
